KẾT QUẢ ĐIỀU TRỊ BỆNH NHÂN UNG THƯ VÚ THỂ DỊ SẢN TẠI BỆNH VIỆN K

Abstract

Aim: We conducted this study to evaluate the treatment outcome of patients with metaplastic breast cancer. Patients and methods: This is a descriptive cohort study on 52 patients with metaplastic breast cancer treated at Vietnam National Cancer Hospital from 2019 to 2022. We collected data on patients’ characteristics, treatment response and survival. Results: There were 19 patients receiving neoadjuvant therapy, of which 9 patients (47.37%) responded to chemotherapy. The rate of 3-year DFS is 70.1%, and the rate of stage I, II, III patients was 100%, 77% and 38.7%, respectively, p=0.003. The 3-year DFS of patients with lymph node metastasis was 47.3%, significantly lower than that of the group without lymph node metastasis (89.9%), p=0.002. Conclusions: Metaplastic breast cancer has poor prognosis, disease stage and lymph node metastasis are associated with with 3-year DFS.